Dallah Healthcare Company (4004)
Tadawul
75.55
+0.25 (+0.33%)
Closed
Oct 4, 2026
Day's Range
74.4575.85
52 wk Range
72.80131.08
Financial Statements - 4004 - Dallah Healthcare Company
Revenue
4.06B▲ 26.9%
Net Income
540.53M▲ 11.4%Net Margin 13.3%
EBITDA
920.42M▲ 17.3%
Free Cash Flow
85.83M▼ 72.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.06B | 3.20B | 2.94B | 2.48B | 2.10B | 1.31B |
| Cost of Goods | 2.61B | 1.99B | 1.86B | 1.59B | 1.34B | 868.52M |
| Gross Profit | 1.45B | 1.20B | 1.07B | 895.10M | 760.36M | 449.72M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 626.41M | 585.40M | 516.55M | 429.84M | 350.14M | 143.51M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 549.52M | 503.39M | 400.31M | 329.13M | 291.83M | 148.41M |
| Income Tax | 8.99M | 18.22M | 14.89M | 33.69M | 16.92M | 13.43M |
| Net Income | 540.53M | 485.17M | 385.42M | 295.44M | 274.91M | 134.97M |
| EPS Basic | 5.32 | 4.83 | 3.7 | 3.05 | 2.87 | 1.53 |
| EPS Diluted | 5.32 | 4.83 | 3.7 | 3.05 | 2.87 | 1.53 |
| Basic Shares Outstanding | 101.18M | 97.53M | 97.34M | 90M | 90M | 86.07M |
| Diluted Shares Outstanding | 101.18M | 97.53M | 97.34M | 90M | 90M | 86.07M |
| Ebit | 697.12M | 610.09M | 504.45M | 399.62M | 333.67M | 173.81M |
| Ebitda | 920.42M | 784.42M | 657.34M | 538.27M | 455.35M | 235.31M |
| Net Income Continuous Operations | 540.53M | 485.17M | 400.31M | 329.13M | 291.83M | 148.41M |
| Minority Interests | -2.26M | -13.97M | -25.30M | -20.97M | -16.30M | -2.97M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
